User profiles for Neda Rasouli
Neda RasouliUniversity of Colorado Anschutz Medical Campus Verified email at cuanschutz.edu Cited by 12209 |
Adipocytokines and the metabolic complications of obesity
Context Adipose tissue is increasingly recognized as an active endocrine organ with many
secretory products and part of the innate immune system. With obesity, macrophages infiltrate …
secretory products and part of the innate immune system. With obesity, macrophages infiltrate …
[HTML][HTML] Vitamin D supplementation and prevention of type 2 diabetes
Background Observational studies support an association between a low blood 25-hydroxyvitamin
D level and the risk of type 2 diabetes. However, whether vitamin D supplementation …
D level and the risk of type 2 diabetes. However, whether vitamin D supplementation …
Insulin resistance in African-American and Caucasian women: differences in lipotoxicity, adipokines, and gene expression in adipose tissue and muscle
Objectives: We tested whether African-American (AA) women are different from Caucasian
women in regard to lipotoxicity, adipokines, and gene expression in adipose tissue and …
women in regard to lipotoxicity, adipokines, and gene expression in adipose tissue and …
Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation
Adipose tissue macrophages are associated with insulin resistance and are linked to changes
in the extracellular matrix. To better characterize adipose macrophages, the extracellular …
in the extracellular matrix. To better characterize adipose macrophages, the extracellular …
Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance …
GB Di Gregorio, A Yao-Borengasser, N Rasouli… - Diabetes, 2005 - Am Diabetes Assoc
To examine the role of adipose-resident macrophages in insulin resistance, we examined the
gene expression of CD68, a macrophage marker, along with macrophage chemoattractant …
gene expression of CD68, a macrophage marker, along with macrophage chemoattractant …
OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization
…, V Varma, A Yao-Borengasser, N Rasouli… - Diabetes, 2006 - Am Diabetes Assoc
Lipid droplet proteins of the PAT (perilipin, adipophilin, and TIP47) family regulate cellular
neutral lipid stores. We have studied a new member of this family, PAT-1, and found that it is …
neutral lipid stores. We have studied a new member of this family, PAT-1, and found that it is …
Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance
Context: Insulin resistance is associated with inflammation, fibrosis, and hypoxia in adipose
tissue. Objective: This study was intended to better characterize the extracellular matrix (ECM…
tissue. Objective: This study was intended to better characterize the extracellular matrix (ECM…
Human visfatin expression: relationship to insulin sensitivity, intramyocellular lipids, and inflammation
V Varma, A Yao-Borengasser, N Rasouli… - The Journal of …, 2007 - academic.oup.com
Context: Visfatin (VF) is a recently described adipokine preferentially secreted by visceral
adipose tissue (VAT) with insulin mimetic properties. Objective: The aim of this study was to …
adipose tissue (VAT) with insulin mimetic properties. Objective: The aim of this study was to …
Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association
Heart failure (HF) has been recognized as a common complication of diabetes, with a
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data also …
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data also …
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3 …
…, S Bao, J White, C Jantzi, N Rasouli… - The lancet Diabetes & …, 2017 - thelancet.com
Background Dapagliflozin is a sodium-glucose cotransporter-2 inhibitor approved for the
treatment of type 2 diabetes. We aimed to assess the efficacy and safety of dapagliflozin as an …
treatment of type 2 diabetes. We aimed to assess the efficacy and safety of dapagliflozin as an …